Quick Links

chronic pain

Brighter prospects for chronic pain

Wed, 2016-04-20 09:37

Researchers use optogenetics to produce pain relief by shutting off neurons with light

The potential of light as a non-invasive, highly-focused alternative to pain medication was made more apparent thanks to research conducted by scientists at the Montreal Neurological Institute and Hospital of McGill University and the McGill University Health Centre.

Contact Information

Contact: Shawn Hayward
Organization: Montreal Neurological Institute and Hospital
Email:
Office Phone: 514 398 3376
Category:
Source Site: /neuro

Location may be key to effectively controlling pain

Targeting the pain receptor at the cell’s nucleus has a major effect on its ability to transmit pain signals
Wed, 2016-02-03 10:06

By Cynthia Lee

Newsroom

In real estate, location is key. It now seems the same concept holds true when it comes to stopping pain. New research published in Nature Communications indicates that the location of receptors that transmit pain signals is important in how big or small a pain signal will be -- and therefore how effectively drugs can block those signals.

Contact Information

Contact: Cynthia Lee
Organization: Media Relations Office - McGill University
Email:
Office Phone: 514 398 6754
Source Site: /newsroom

Chronic pain changes our immune systems

Epigenetics may bring us one step closer to better treatments for chronic pain
Thu, 2016-01-28 06:39

By Cynthia Lee
Newsroom

Chronic pain may reprogram the way genes work in the immune system, according to a new study by McGill University researchers published in the journal Scientific Reports.  

Contact Information

Contact: Cynthia Lee
Organization: Media Relations Office - McGill University
Email:
Office Phone: 514-398-6754
Source Site: /newsroom

American Placebo

New analysis of chronic pain drug trials shows increasing placebo responses over time, in the U.S. only
Tue, 2015-10-06 12:17

A new study finds that rising placebo responses may play a part in the increasingly high failure rate for clinical trials of drugs designed to control chronic pain caused by nerve damage.

Contact Information

Contact: Prof. Jeffrey Mogil
Organization: Department of Psychology, McGill University
Email:

Secondary Contact Information

Contact: Chris Chipello
Organization: Media Relations
Office Phone: 514-398-4201
Category:
Source Site: /newsroom

How insulin calms brain activity

New role for “diabetes hormone” may lead to gains in treatment options for brain disorders
Tue, 2015-06-30 16:51

Insulin has long been known as the hormone which controls the body’s sugar levels: humans who lack or are insensitive to insulin develop diabetes. Although insulin is also made and released in the brain, its effects there have remained unclear.

Contact Information

Contact: Melody Enguix
Organization: Media Relations Office
Email:
Office Phone: 514 398 6751
Source Site: /newsroom

New hope in the fight against pain

Study shows potential new therapy for neuropathic pain
Tue, 2015-02-17 11:19

An international study led by scientists at McGill University reports, for the first time, that drugs that selectively target the melatonin MT2 receptor represent a novel class of analgesic drugs that could be used to treat patients with neuropathic pain.

Contact Information

Contact: Cynthia Lee
Organization: McGill University
Email:
Office Phone: 514-398-6754
Category:
Source Site: /newsroom

Pain curbs sex drive in female mice, but not in males

Findings could help scientists study pain-inhibited sexual desire in humans
Tue, 2014-04-22 17:09

“Not tonight, dear, I have a headache.” Generally speaking, that line is attributed to the wife in a couple, implying that women’s sexual desire is more affected by pain than men’s.

Contact Information

Contact: Chris Chipello
Organization: Media Relations Office
Email:
Office Phone: 514-398-4201

Secondary Contact Information

Contact: Jeffrey Mogil
Organization: Department of Psychology
Category:
Source Site: /newsroom